CEO SUMMARY: With little fanfare, Aurora Diagnostics, Inc. opened for business last summer. It states that it has already signed acquisition agreements with five different pathology groups. Former AmeriPath executives James C. New and Martin J. Stefanelli are leading Aurora Diagnostics. Handling business development activities for Aurora will be Christopher Jahnle and Kirk Rebane of […]
To access this post, you must purchase The Dark Report.